Laurie Porter, DO
Otolaryngology · Nashua, NHNPI 1386664902
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $175 of the $228 with a category attached, or 76.7%. 6 manufacturers reported payments, led by Sanofi at 45.3% of the total. 2025 is the largest year on record at $196, more than ten times the $7 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in NH, where the typical reported total is $397.
Across 9 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$103
- Sanofi-aventis U.S. LLC$53
- GSK$25
- Regeneron Healthcare Solutions, Inc.$24
- Vertex$16
- Aerin Medical Inc.$7
What the payments were for
- Food & beverage$17577%
- Education$5323%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 4 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| GSK | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Vertex | 1 | $16 |
| Aerin Medical Inc. | 1 | $7 |
How this compares
$228 in reported general payments places this provider in the 40th percentile of 44 otolaryngology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $43,815 |
| Ipratropium Bromide | 149 | $4,863 |
| Azelastine Hcl | 105 | $2,968 |
| Epinephrine | 12 | $2,857 |
| Famotidine | 323 | $2,852 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 24 | $2,657 |
| Fluocinolone Acetonide Oil | 28 | $1,281 |
| Montelukast Sodium | 49 | $1,221 |
| Fluticasone Propionate | 76 | $1,025 |
| Mupirocin | 43 | $338 |
| Pantoprazole Sodium | 25 | $282 |
| Methylprednisolone | 25 | $247 |
| Omeprazole | 18 | $152 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $145 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $87 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Nashua
- Ashok ReddyNashua$1K
- James BartelsManchester$5K
- Joseph PaydarfarLebanon$5K
- Michael ToscanoDover$4K
- Taraneh AzarPortsmouth$4K
- Christopher KnoxRochester$3K
- Avery NelsonKeene$2K
- Keith JorgensenDerry$2K
- Ross JohnstonLebanon$2K
- Carly SchrageLaconia$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.